KLRK1 and autoimmune disease: The involvement of NKG2D and its ligands in autoimmune diseases was first revealed in RA, but has also been described in type I diabetes (Ogasawara et al., 2004; Blevins et al., 2012; Babic and Romagnani, 2018).